TransMedics Group Inc

TMDX

Company Profile

  • Business description

    TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

  • Contact

    200 Minuteman Road
    AndoverMA01810
    USA

    T: +1 978 552-0900

    https://www.transmedics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    898

Stocks News & Analysis

stocks

Chip stock selloff deepens in Asia, extends to Europe and US

The week’s tech stock rout continues despite strong earnings from TSMC and ASML.
stocks

Downgrade for ASX listed fund manager as redemptions pile on

Persistent outflows erode earnings outlook.
stocks

Tesla stock is down nearly 20% this year. Is it a buy ahead of earnings?

Following the rollout of its first autonomous Cybercab, here’s what we expect from Tesla’s earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,940.40100.001.13%
CAC 407,956.7022.000.28%
DAX 4025,622.61239.990.95%
Dow JONES (US)52,002.41175.28-0.34%
FTSE 10010,881.9041.550.38%
HKSE24,186.83124.110.52%
NASDAQ26,140.03572.99-2.14%
Nikkei 22565,324.29898.341.39%
NZX 50 Index13,753.7379.07-0.57%
S&P 5007,659.4484.62-1.09%
S&P/ASX 2008,806.7087.001.00%
SSE Composite Index3,716.288.810.24%

Market Movers